2021
DOI: 10.3390/cells10010080
|View full text |Cite
|
Sign up to set email alerts
|

SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells

Abstract: Bladder cancer is a very heterogeneous disease and the molecular mechanisms of carcinogenesis and progression are insufficiently investigated. From the DNA sequencing analysis of matched non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) samples from eight patients, we identified the tumour-associated gene SLC35F2 to be mutated in the 5′ and 3′ untranslated region (UTR). One mutation in 3′UTR increased the luciferase activity reporter, suggesting its influence on the protein e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…The postoperative recurrence rate of NMIBC exceeds 70%; approximately 15% of these patients progress to MIBC. The postoperative recurrence rate of patients with MIBC can exceed 50% after radical cystectomy (RC), and many patients can die from this disease ( Kotolloshi et al, 2021 ; Zhang et al, 2021 ). Because of the different prognoses and biological pathways underlying NMIBC and MIBC, a range of different treatment strategies may be required ( Nouhaud et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…The postoperative recurrence rate of NMIBC exceeds 70%; approximately 15% of these patients progress to MIBC. The postoperative recurrence rate of patients with MIBC can exceed 50% after radical cystectomy (RC), and many patients can die from this disease ( Kotolloshi et al, 2021 ; Zhang et al, 2021 ). Because of the different prognoses and biological pathways underlying NMIBC and MIBC, a range of different treatment strategies may be required ( Nouhaud et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…A previous study discovered a novel apoptosis-resistant pathway that promoted both immune suppression and oncogenic cell proliferation by modulating the expression of the FOXO family [ 78 ], and these are suspected to promote tumor progression. In our study, accompanied with the self-protection against apoptotic activation, a list of mRNAs including Gcm1 [ 79 ], DHRS3 [ 40 ], DUSP5 [ 80 ], NBL1 , EPN1 , SLC9A3R2 [ 81 ], SLC35F2 [ 82 ], and FOXA3 [ 83 ] involved in the cell proliferation, were significantly increased by the lactate treatment. Solute carriers (SLCs), ranking second among membrane transport proteins in terms of abundance [ 84 ], play crucial roles in human physiology through processes such as the intake of amino acids in the intestine for cell growth [ 85 ].…”
Section: Discussionmentioning
confidence: 94%
“…Detailed methodology is given as described previously [ 40 ]. Tumor specimens were collected from bladder cancer patients at the Department of Urology, Jena University Hospital, Germany.…”
Section: Methodsmentioning
confidence: 99%